|Articles|March 15, 2008

Parkinsonâ€™s Disease: Quality Assessment and Improvement of Care
Volume 14
Issue 2 Suppl

Parkinson"s Disease: Quality Assessment and Improvement of Care

Download PDF: Parkinson"s Disease: Quality Assessment and Improvement of Care

Articles in this issue

over 18 years ago

Article

Part 3: Neuropsychiatric Symptoms

over 18 years ago

Article

Part 2: Treatment of Motor Symptoms

over 18 years ago

Article

Introduction

over 18 years ago

Article

Part 1: Pathophysiology, Symptoms, Burden, Diagnosis, and Assessment

over 18 years ago

Article

Participating Faculty

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Parkinson"s Disease: Quality Assessment and Improvement of Care

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

Judge Denies Preliminary Injunction in Medicaid Work Requirements Case

Wildfire Smoke Raises Asthma Risks as Fires Worsen Air Quality Across North America

Can Oral Semaglutide Reduce Heavy Drinking in Alcohol Use Disorder?

Acoramidis Attenuates Decline in Heart Failure–Related Health Status in ATTR-CM

Why Cutting Trial Red Tape Won't Fix Clinical Trial Design